DRUG FOR PREVENTION OR TREATMENT OF BRAIN ATROPHY Russian patent published in 2021 - IPC A61K31/397 A61P25/28 

FIELD: medicine.

SUBSTANCE: invention relates to the application of pharmacologically acceptable salt of 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)azetidine-3-ole as an active ingredient in a drug for the prevention or treatment of brain atrophy, where the drug is injected to a patient with Alzheimer’s disease of mild and moderate severity, preclinical Alzheimer’s disease, prodromal period of Alzheimer’s disease or mild cognitive impairment caused by Alzheimer’s disease (MCI due to AD) daily at a dosage from 100 mg to 400 mg per one dosage of 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)azetidine-3-ole on injection.

EFFECT: obtaining a drug for the prevention or treatment of brain atrophy.

3 cl, 4 dwg, 3 tbl, 3 ex